SM
SG3 Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-64,500
| Closed | -$909K | – | 74 |
|
2022
Q2 | $909K | Buy |
64,500
+6,463
| +11% | +$91.1K | 0.11% | 14 |
|
2022
Q1 | $1.41M | Buy |
+58,037
| New | +$1.41M | 0.04% | 47 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 299 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 251 |
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$258K | – | 274 |
|
2021
Q1 | $258K | Buy |
+10,000
| New | +$258K | 0.01% | 206 |
|
2019
Q3 | – | Sell |
-7,500
| Closed | -$200K | – | 81 |
|
2019
Q2 | $200K | Hold |
7,500
| – | – | 0.02% | 50 |
|
2019
Q1 | $201K | Buy |
+7,500
| New | +$201K | 0.02% | 42 |
|